Evidence map›Paper›PMID 36901345›Full record

ArticleInternational journal of environmental research and public health2023

Physical, Psychiatric, and Social Comorbidities of Individuals with Schizophrenia Living in the Community in Japan.

Masaaki Matsunaga, Yuanying Li, Yupeng He, Taro Kishi, Shinichi Tanihara, Nakao Iwata, Takahiro Tabuchi, Atsuhiko Ota

Full text read
In one paragraph

Article in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Masaaki MatsunagaDepartment of Public Health, Fujita Health University School of Medicine, Toyoake 470-1192, Japan.ORCID 0000-0001-7942-1446
Yuanying LiDepartment of Public Health and Health Systems, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan.
Yupeng HeDepartment of Public Health, Fujita Health University School of Medicine, Toyoake 470-1192, Japan.ORCID 0000-0003-3162-0176
Taro KishiDepartment of Psychiatry, School of Medicine, Fujita Health University, Toyoake 470-1192, Japan.
Shinichi TaniharaDepartment of Public Health, School of Medicine, Kurume University, Kurume 830-0011, Japan.
Nakao IwataDepartment of Psychiatry, School of Medicine, Fujita Health University, Toyoake 470-1192, Japan.
Takahiro TabuchiCancer Control Center, Osaka International Cancer Institute, Osaka 541-8567, Japan.ORCID 0000-0002-1050-3125
Atsuhiko OtaDepartment of Public Health, Fujita Health University School of Medicine, Toyoake 470-1192, Japan.ORCID 0000-0001-6452-1823

Funding

Health and Labour Sciences Research grant from the Ministry of Health, Labour and Welfare, Japan JPMH21GC1018
6 · The paper itself

Abstract

The physical, psychiatric, and social comorbidities interfere with the everyday activities of community-dwelling individuals with schizophrenia and increase the risk of their readmission. However, these comorbidities have not been investigated comprehensively in Japan. We conducted a self-reported internet survey in February 2022 to identify individuals aged 20-75 years with and without schizophrenia using a prevalence case-control study. The survey compared physical comorbidities such as being overweight, hypertension, and diabetes; psychiatric comorbidities such as depressive symptoms and sleep disturbances; social comorbidities such as employment status, household income, and social support between participants with and without schizophrenia. A total of 223 participants with schizophrenia and 1776 participants without schizophrenia were identified. Participants with schizophrenia were more likely to be overweight and had a higher prevalence of hypertension, diabetes, and dyslipidemia than participants without schizophrenia. Additionally, depressive symptoms, unemployment, and non-regular employment were more prevalent in participants with schizophrenia than those without schizophrenia. These results highlight the necessity of comprehensive support and interventions addressing physical, psychiatric, and social comorbidities in individuals with schizophrenia in the community. In conclusion, effective interventions for managing comorbidities in individuals with schizophrenia are necessary to enable them to continue to live in the community.

Indexed as

Diabetes MellitusHypertensionSchizophreniaCase-Control StudiesHumansJapanOverweightcommunity supportcomorbiditydepressionepidemiologyschizophrenia

Identifiers

PMID36901345
PMCPMC10001945

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read100
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.